All In MedTech

Device Trial Radar · NCT06491173

Detecting Traumatic Intracranial Hemorrhage With the InfraScanner 2500™ in Uganda

Assessment of Accuracy, Precision, and Feasibility of a Handheld Near-Infrared Light Device (InfraScanner 2500™) in Detecting Traumatic Intracranial Hemorrhage in Uganda

Last checked: Nov 20, 2026Latest source record: Feb 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

180

Actual

Start

Jul 30, 2024

Primary completion

Feb 28, 2025

Study completion Mar 30, 2025

Sponsor

Lead sponsor
Duke UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Mbarara Regional Referral Hospital; Mayanja Memorial Hospital
First posted
Jul 8, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
Yes
Who can join
All sexes, from 12 years, up to 99 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this study is to determine the sensitivity, specificity, and positive and negative predictive values of the portable near-infrared-based device (portable NIR-based device), the InfraScanner 2500™, to detect intracranial hematomas (epidural hematomas (EDH) and/or subdural hematomas (SDH)) in patients hospitalized at Mbarara Regional Referral Hospital (MRRH) or Mayanja Memorial Hospital (MMH) who have sustained or who are suspected to have sustained head trauma.

Conditions

  • Head Trauma
  • Crushing Skull Injury
  • Head Injury
  • Head Injuries, Multiple
  • Head Injuries, Closed
  • Head Trauma,Closed
  • Head Injury Major
  • Head Injury, Minor
  • Head Injury, Open
  • Injury, Craniocerebral
  • Injury, Head
  • Multiple Head Injury
  • Trauma, Head
  • Head Trauma Injury
  • Head Trauma, Penetrating
  • Craniocerebral Injury

Interventions

  • InfraScanner 2500™Device

    The Infrascanner is a portable screening device that uses Near-Infrared (NIR) technology to screen patients for intracranial bleeding, identifying those who would most benefit from immediate referral to a CT scan and neurosurgical intervention.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Infrascanner 2500™ Diagnostic PerformanceTime frame: Within 30 minutes following CT scan

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Mayanja Memorial Hospital

    Mbarara, Uganda

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.